Literature DB >> 19035480

Disparate folding and stability of the ankylosing spondylitis-associated HLA-B*1403 and B*2705 proteins.

Elena Merino1, Begoña Galocha, Miriam N Vázquez, José A López de Castro.   

Abstract

OBJECTIVE: To investigate the folding, assembly, maturation, and stability of HLA-B*1402 and B*1403, which differ by 1 amino acid change and are differentially associated with ankylosing spondylitis (AS), and to compare these features with those of B*2705.
METHODS: Stable transfectants expressing B*1402, B*1403, and B*2705 were used. Folding rates were estimated from the ratio of unfolded heavy chains to folded heavy chains that had been immunoprecipitated with specific antibodies in pulse-chase experiments. Heavy chain misfolding was measured as the half-life of endoglycosidase H (Endo H)-sensitive beta2-microglobulin-free heavy chains. Maturation/export rates were measured by acquisition of Endo H resistance. Association with calnexin or tapasin was analyzed by coprecipitation with chaperone-specific antibodies, and surface expression was estimated by flow cytometry. Thermostability of HLA-peptide complexes was assessed by immunoprecipitation after incubation at various temperatures. Heavy chain expression was quantified by Western blotting.
RESULTS: The folding rates of B*1402 and B*1403 were similar, and both were faster and more efficient than B*2705, but some unfolded heavy chains from both B14 subtypes remained in the endoplasmic reticulum (ER) with a long half-life. The export rates of B*1402 and B*1403 were slow, and the heterodimers partially dissociated after exiting the ER, as revealed by significant amounts of Endo H-resistant and surface-expressed free heavy chains. Both interaction with tapasin and thermostability were higher for B*2705 than for B*1402 and higher for B*1402 than for B*1403, suggesting that the repertoires of the B*1402-bound peptide and especially the B*1403-bound peptide were less optimized than that of B*2705.
CONCLUSION: Our results indicate that the folding, maturation, and stability of B*1403 differ more from B*2705 than from B*1402. Thus, these features cannot account for the fact that only the 2 former allotypes are associated with AS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19035480     DOI: 10.1002/art.24045

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  10 in total

1.  Mutational analysis reveals a complex interplay of peptide binding and multiple biological features of HLA-B27.

Authors:  Begoña Galocha; José A López de Castro
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

Review 2.  Revisiting MHC genes in spondyloarthritis.

Authors:  Maxime Breban; Félicie Costantino; Claudine André; Gilles Chiocchia; Henri-Jean Garchon
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

Review 3.  Recent studies on the genetic basis of ankylosing spondylitis.

Authors:  John D Reveille
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

Review 4.  An update on the contribution of the MHC to AS susceptibility.

Authors:  John D Reveille
Journal:  Clin Rheumatol       Date:  2014-05-18       Impact factor: 2.980

5.  Peptide handling by HLA-B27 subtypes influences their biological behavior, association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1).

Authors:  Noel García-Medel; Alejandro Sanz-Bravo; Carlos Alvarez-Navarro; Patricia Gómez-Molina; Eilon Barnea; Miguel Marcilla; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2014-09-03       Impact factor: 5.911

Review 6.  From HLA-B27 to spondyloarthritis: a journey through the ER.

Authors:  Robert A Colbert; Monica L DeLay; Erin I Klenk; Gerlinde Layh-Schmitt
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

7.  Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens.

Authors:  Pravin Kumar; Ardeschir Vahedi-Faridi; Wolfram Saenger; Elena Merino; José A López de Castro; Barbara Uchanska-Ziegler; Andreas Ziegler
Journal:  J Biol Chem       Date:  2009-07-18       Impact factor: 5.157

8.  Functional interaction of the ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo.

Authors:  Noel García-Medel; Alejandro Sanz-Bravo; Dung Van Nguyen; Begoña Galocha; Patricia Gómez-Molina; Adrián Martín-Esteban; Carlos Alvarez-Navarro; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2012-08-23       Impact factor: 5.911

9.  Targeted delivery of an antigenic peptide to the endoplasmic reticulum: application for development of a peptide therapy for ankylosing spondylitis.

Authors:  Hui-Chun Yu; Ming-Chi Lu; Chin Li; Hsien-Lu Huang; Kuang-Yung Huang; Su-Qin Liu; Ning-Sheng Lai; Hsien-Bin Huang
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

10.  Distinct mechanisms survey the structural integrity of HLA-B*27:05 intracellularly and at the surface.

Authors:  Zeynep Hein; Britta Borchert; Esam Tolba Abualrous; Sebastian Springer
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.